"Patients with uveitis, the fifth leading cause of vision loss in the
United States, treated with either systemic anti-inflammatory medicine
or with a time-release implant surgically placed inside the eye
experienced a similar degree of visual improvement over two years,
according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania, the Mount Sinai School of Medicine, Johns Hopkins University and the University of Wisconsin," according to a PennMedicine press release. "Results from the Multicenter Uveitis Steroid Treatment (MUST) Trial, supported by the National Eye Institute (NEI), are published online in the journal Ophthalmology." Read more.
